At the WIRED Health summit last week, Harvard biochemist and gene-editing pioneer David Liu says later this year his lab plans to report on a single gene-editing strategy that could treat many unrelated diseases. He calls it disease-agnostic therapeutic gene editing.
“It sounds sort of crazy,…